The other day Bob Grant of The Scientist interviewed me on who might be the next FDA commissioner. He mostly got it right.
There is one bit of reportage that does, however, need to be corrected. Here’s what was written:
“Peter Pitts, president of the Center for Medicine in the Public Interest (CMPI) and former FDA staffer, confirmed those rumors, both on DrugWonks.com -- CMPI's blog -- and when I called him yesterday. Pitts, who has advised the Obama transition team, said that Sharfstein and Califf were the only two names receiving serious consideration.”
Almost right. What I told Grant was that I thought the two most serious candidates for the job are Sharfstein and Califf. Whether or not the Obama team is considering others is above my pay grade.
To view the complete interview in The Scientist, see here.
There is one bit of reportage that does, however, need to be corrected. Here’s what was written:
“Peter Pitts, president of the Center for Medicine in the Public Interest (CMPI) and former FDA staffer, confirmed those rumors, both on DrugWonks.com -- CMPI's blog -- and when I called him yesterday. Pitts, who has advised the Obama transition team, said that Sharfstein and Califf were the only two names receiving serious consideration.”
Almost right. What I told Grant was that I thought the two most serious candidates for the job are Sharfstein and Califf. Whether or not the Obama team is considering others is above my pay grade.
To view the complete interview in The Scientist, see here.
